[Cardiac resynchronization therapy: who is suitable? Who requires an additional ICD as a backup?]

Area of Science:

• Cardiology
• Medical Devices

Context:

• Congestive heart failure (CHF) patients with NYHA classes III-IV, reduced ventricular function, and left bundle branch block (LBBB) often benefit from CRT.
• CRT significantly improves quality of life and reduces mortality in these patients.

Purpose:

• To evaluate the prognostic benefits of combining CRT with an implantable cardioverter-defibrillator (ICD).
• To determine if all CRT-eligible patients require an ICD, considering mixed study outcomes.

Summary:

• CRT offers substantial benefits for specific heart failure patient groups, including improved cardiopulmonary stress management and reduced mortality.
• The addition of an ICD to CRT may further improve prognosis by reducing sudden cardiac death.
• Contradictory findings necessitate further discussion on the universal need for ICDs in all CRT candidates.

Impact:

• Provides clarity on the indications for ICD implantation in CRT patients.
• Aims to optimize patient selection for combined CRT-ICD therapy.
• Contributes to evidence-based guidelines for managing advanced heart failure and reducing sudden cardiac death.